International Biotechnology Trust plc (IBT) — Net Asset Quality Index
International Biotechnology Trust plc (IBT) has a Net Asset Quality Index of 87.8% as of August 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX284.04 Million minus total liabilities of GBX34.63 Million yields net assets of GBX249.41 Million. A higher index indicates a stronger, lower-leverage balance sheet. See International Biotechnology Trust plc (IBT) liquidity interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
International Biotechnology Trust plc Net Asset Quality Index Over Time (2000–2025)
This chart shows how International Biotechnology Trust plc's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of August 2025, the index stands at 87.8%, representing net assets of GBX249.41 Million against total assets of GBX284.04 Million GBX. Explore how efficiently does International Biotechnology Trust plc generate cash to assess how effectively this company generates cash.
Annual Net Asset Quality Index for International Biotechnology Trust plc (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for International Biotechnology Trust plc from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see International Biotechnology Trust plc market capitalisation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.8% | GBX249.41 Million | GBX284.04 Million | GBX34.63 Million | ▼ -3.8 pp |
| 2024 | 91.6% | GBX282.26 Million | GBX308.15 Million | GBX25.89 Million | ▲ +2.9 pp |
| 2023 | 88.7% | GBX270.32 Million | GBX304.87 Million | GBX34.55 Million | ▲ +1.5 pp |
| 2022 | 87.1% | GBX284.89 Million | GBX326.92 Million | GBX42.03 Million | ▼ -5.9 pp |
| 2021 | 93.1% | GBX323.77 Million | GBX347.83 Million | GBX24.06 Million | ▼ -0.7 pp |
| 2020 | 93.8% | GBX283.90 Million | GBX302.71 Million | GBX18.81 Million | ▼ -6.2 pp |
| 2019 | 100.0% | GBX240.82 Million | GBX240.86 Million | GBX42.00K | ▲ +0.3 pp |
| 2018 | 99.7% | GBX262.47 Million | GBX263.22 Million | GBX744.00K | ▲ +6.9 pp |
| 2017 | 92.8% | GBX252.65 Million | GBX272.34 Million | GBX19.69 Million | ▼ -1.0 pp |
| 2016 | 93.7% | GBX216.65 Million | GBX231.12 Million | GBX14.47 Million | ▲ +3.6 pp |
| 2015 | 90.2% | GBX236.00 Million | GBX261.68 Million | GBX25.68 Million | ▼ -5.1 pp |
| 2014 | 95.3% | GBX214.97 Million | GBX225.61 Million | GBX10.64 Million | ▼ -4.6 pp |
| 2013 | 99.9% | GBX172.67 Million | GBX172.90 Million | GBX224.00K | ▲ +0.0 pp |
| 2012 | 99.8% | GBX128.92 Million | GBX129.12 Million | GBX199.00K | ▲ +9.3 pp |
| 2011 | 90.6% | GBX91.76 Million | GBX101.32 Million | GBX9.55 Million | ▼ -7.9 pp |
| 2010 | 98.5% | GBX93.66 Million | GBX95.07 Million | GBX1.41 Million | ▼ -1.0 pp |
| 2009 | 99.5% | GBX98.25 Million | GBX98.72 Million | GBX464.00K | ▲ +0.5 pp |
| 2008 | 99.0% | GBX113.52 Million | GBX114.69 Million | GBX1.17 Million | ▲ +0.7 pp |
| 2007 | 98.3% | GBX102.36 Million | GBX104.11 Million | GBX1.75 Million | ▼ -1.4 pp |
| 2006 | 99.8% | GBX66.95 Million | GBX67.12 Million | GBX167.00K | ▲ +1.0 pp |
| 2005 | 98.8% | GBX58.00 Million | GBX58.73 Million | GBX731.00K | ▼ -0.6 pp |
| 2004 | 99.3% | GBX55.15 Million | GBX55.53 Million | GBX378.00K | ▲ +0.1 pp |
| 2003 | 99.2% | GBX53.93 Million | GBX54.34 Million | GBX410.00K | ▲ +0.6 pp |
| 2002 | 98.7% | GBX47.90 Million | GBX48.54 Million | GBX643.00K | ▲ +0.5 pp |
| 2001 | 98.2% | GBX98.74 Million | GBX100.58 Million | GBX1.84 Million | ▲ +2.8 pp |
| 2000 | 95.4% | GBX349.33 Million | GBX366.17 Million | GBX16.84 Million | — |